share_log

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36

HC Wainwright & Co.维持对格林威治生命科学的买入,将目标股价下调至36美元
Benzinga ·  02/20 07:47

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price target from $38 to $36.

HC Wainwright & Co. 分析师陈毅维持格林威治生命科学(纳斯达克股票代码:GLSI)的买入并将目标股价从38美元下调至36美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发